Pain Clinical Trial
A Long Term, Open-Label, Multi-Center Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
|Source||Taiwan Mundipharma Pharmaceuticals Ltd.|
|Contact||Brook Chung, MSc|
|Start date||October 31, 2016|
|Completion date||December 31, 2018|
This study is to evaluate the safety and tolerability of oxycodone control-released (CR) and/or immediate-released (IR) use in patients with moderate to severe cancer pain in a 3-months period in Taiwan.
This is an open label, long-term study carrying in multi-centers. Around 200 patients with
moderate to severe cancer pain (NRS ≥ 4) who agreed and signed informed consent will be
enrolled to receive oxycodone with continuous around-the-clock pattern. The study is to
evaluate the safety and tolerability of cancer patients who receive CR and/or IR oxycodone.
The number and percentage of patients with adverse events and serious adverse events will be
recorded throughout the study.
The study will continue for 3 months to observe the safety and tolerability. After screening at Screening visit, patients begin the study by the first day visit (Day 1). Pain assessment, study related questionnaires are giving out to measure the baseline scale of each patient. Questionnaires including rate of quality of analgesia, EQ-5D and clinical opiate withdrawal scale (COWS). The prescription of the study drug will be recorded from Day 1. Patients will need to visit bi-weekly, including Wk 2 (Day 14±3), Wk 4 (Day 28±3), Wk 6 (Day 42±3), Wk 8 (Day 56±3), Wk 10 (Day 70±3) and Wk 12 (Day 84±3). Pain assessment will be assessed in each visit, drug accountability will be recorded accordingly. The rate of quality of Analgesia will be assessed in each visit; QoL (EQ-5D) will be recorded in Wk 4, Wk 8 and Wk 12. The COWS will be assessed again in Wk 12.
The safety for individual patient will be followed during study up to 2 weeks after the end of treatment (EOT) or early termination (ET). The telephone contact for safety follow-up is acceptable for this study.
|Completed||NCT01441141 - Genetics and Pain Severity in Sickle Cell Disease||N/A|
|Completed||NCT02913027 - Can We Improve the Comfort of Pelvic Exams?||N/A|
|Terminated||NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?||N/A|
|Completed||NCT01077414 - Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness||N/A|
|Completed||NCT01198197 - PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A||Early Phase 1|
|Recruiting||NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)||Phase 4|
|Recruiting||NCT02943772 - Does Local Cooling of Testis in Patients With Epididymitis Relieve Pain and Reduce Quantity of Analgetics Intake?||N/A|
|Recruiting||NCT02917603 - Shared Decision Making to Improve Palliative Care in the Nursing Home||N/A|
|Recruiting||NCT02911168 - Comparison of US-Guided Paravertebral and Proximal Intercostal Nerve Blocks||N/A|
|Recruiting||NCT02829736 - ThOracoscopic Wedge Resection Treated With Chest Tube Removal Intraoperatively||N/A|
|Recruiting||NCT02885051 - Evaluation of Pain in Preterm Newborn||N/A|
|Recruiting||NCT02913833 - The Impact of Pain Assessment on the Hospital Length of Stay of Patients in a Rehabilitation Unit||N/A|
|Not yet recruiting||NCT02819544 - Evaluation of the Interest of the Instillation of Saline Intraperitoneally (INSI ) Versus Instillation of Naropin the Surgical Site Versus Lung Recruitment Maneuvers ( PVM ) in the Management of Pain After Laparoscopic Cholecystectomy in Ambulatory Care||Phase 3|
|Not yet recruiting||NCT02840942 - Robots to Reduce Pain During IV Placement||N/A|
|Completed||NCT02876705 - Spatiotemporal Patterns of Pain During Exercise||Phase 0|
|Not yet recruiting||NCT02840838 - Botulinum Toxin for Post Abdominoplasty Pain Control||Phase 4|
|Not yet recruiting||NCT02834481 - Assessment of Pain Monitoring With ANI/NIPE Monitor Program in Pediatric Cardiac Surgery Postoperative.||Phase 4|
|Not yet recruiting||NCT02854553 - TAP Block Alone Versus TAPblock With Rectus Sheath Block in Liposuction Surgery||N/A|
|Not yet recruiting||NCT02851940 - Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids||N/A|
|Not yet recruiting||NCT02847013 - The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section||Phase 2/Phase 3|